Literature DB >> 21703170

Does adherence to hepatitis B antiviral treatment correlate with virological response and risk of breakthrough?

Marie Noelle Hilleret, Sylvie Larrat, Francoise Stanke-Labesque, Vincent Leroy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21703170     DOI： 10.1016/j.jhep.2011.04.006

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  7 in total

1.  Treatment Adherence to Nucleos(t)ide Analogs in Chinese Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Single-Center Cross-Sectional Study.

Authors:  Yueyue Li; Anni Chen; Hui Wang; Lu Han; Rong Wang; Guoqing Zhang; Yongfang Yuan
Journal:  Patient Prefer Adherence       Date:  2021-08-10       Impact factor: 2.711

Review 2.  INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.

Authors:  Anil Arora; Shivaram P Singh; Ashish Kumar; Vivek A Saraswat; Rakesh Aggarwal; Manisha Bangar; Pradip Bhaumik; Harshad Devarbhavi; Radha K Dhiman; Vinod K Dixit; Ashish Goel; Bhabadev Goswami; Dharmesh Kapoor; Kaushal Madan; Jimmy Narayan; Sandeep Nijhawan; Gaurav Pandey; Ramesh R Rai; Manoj K Sahu; Neeraj Saraf; Thrivikrama Shenoy; Varghese Thomas; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2017-12-16

3.  Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study.

Authors:  Jie Peng; Junhua Yin; Shaohang Cai; Tao Yu; Chunxiu Zhong
Journal:  Patient Prefer Adherence       Date:  2015-01-07       Impact factor: 2.711

4.  Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B.

Authors:  Rodrigo Martins Abreu; Camila da Silva Ferreira; Aline Siqueira Ferreira; Eduardo Remor; Paulo Dominguez Nasser; Flair José Carrilho; Suzane Kioko Ono
Journal:  Infect Dis Ther       Date:  2016-01-13

5.  Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes.

Authors:  Nicole L Allard; Jennifer H MacLachlan; Anouk Dev; James Dwyer; Geeta Srivatsa; Timothy Spelman; Alexander J Thompson; Benjamin C Cowie
Journal:  BMC Gastroenterol       Date:  2020-05-07       Impact factor: 3.067

6.  Composition and Interactions of Hepatitis B Virus Quasispecies Defined the Virological Response During Telbivudine Therapy.

Authors:  Bin Zhou; Hui Dong; Yungang He; Jian Sun; Weirong Jin; Qing Xie; Rong Fan; Minxian Wang; Ran Li; Yangyi Chen; Shaoqing Xie; Yan Shen; Xin Huang; Shengyue Wang; Fengming Lu; Jidong Jia; Hui Zhuang; Stephen Locarnini; Guo-Ping Zhao; Li Jin; Jinlin Hou
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

Review 7.  Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis.

Authors:  Nathan Ford; Roz Scourse; Maud Lemoine; Yvan Hutin; Marc Bulterys; Zara Shubber; Dmytro Donchuk; Gilles Wandeler
Journal:  Hepatol Commun       Date:  2018-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.